246 related articles for article (PubMed ID: 24312699)
1. Analogs of the Allosteric Heat Shock Protein 70 (Hsp70) Inhibitor, MKT-077, as Anti-Cancer Agents.
Li X; Srinivasan SR; Connarn J; Ahmad A; Young ZT; Kabza AM; Zuiderweg ER; Sun D; Gestwicki JE
ACS Med Chem Lett; 2013 Nov; 4(11):1042-7. PubMed ID: 24312699
[TBL] [Abstract][Full Text] [Related]
2. Analogs of the Heat Shock Protein 70 Inhibitor MKT-077 Suppress Medullary Thyroid Carcinoma Cells.
Hong SK; Starenki D; Johnson OT; Gestwicki JE; Park JI
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35162987
[TBL] [Abstract][Full Text] [Related]
3. A Local Allosteric Network in Heat Shock Protein 70 (Hsp70) Links Inhibitor Binding to Enzyme Activity and Distal Protein-Protein Interactions.
Rinaldi S; Assimon VA; Young ZT; Morra G; Shao H; Taylor IR; Gestwicki JE; Colombo G
ACS Chem Biol; 2018 Nov; 13(11):3142-3152. PubMed ID: 30372610
[TBL] [Abstract][Full Text] [Related]
4. Exploration of Benzothiazole Rhodacyanines as Allosteric Inhibitors of Protein-Protein Interactions with Heat Shock Protein 70 (Hsp70).
Shao H; Li X; Moses MA; Gilbert LA; Kalyanaraman C; Young ZT; Chernova M; Journey SN; Weissman JS; Hann B; Jacobson MP; Neckers L; Gestwicki JE
J Med Chem; 2018 Jul; 61(14):6163-6177. PubMed ID: 29953808
[TBL] [Abstract][Full Text] [Related]
5. Neutral analogs of the heat shock protein 70 (Hsp70) inhibitor, JG-98.
Shao H; Gestwicki JE
Bioorg Med Chem Lett; 2020 Mar; 30(5):126954. PubMed ID: 31952963
[TBL] [Abstract][Full Text] [Related]
6. Development of Novel Rhodacyanine-Based Heat Shock Protein 70 Inhibitors.
Chang CS; Kumar V; Lee DY; Chen Y; Wu YC; Gao JY; Chu PC
Curr Med Chem; 2021; 28(26):5431-5446. PubMed ID: 33538660
[TBL] [Abstract][Full Text] [Related]
7. Analyzing Interaction of Rhodacyanine Inhibitor 'MKT-077' with
Nainani C; Upadhyay V; Singh B; Sandhu KK; Kaur S; Hora R; Mishra PC
Drug Metab Bioanal Lett; 2024 Jan; ():. PubMed ID: 38231055
[TBL] [Abstract][Full Text] [Related]
8. X-linked inhibitor of apoptosis protein (XIAP) is a client of heat shock protein 70 (Hsp70) and a biomarker of its inhibition.
Cesa LC; Shao H; Srinivasan SR; Tse E; Jain C; Zuiderweg ERP; Southworth DR; Mapp AK; Gestwicki JE
J Biol Chem; 2018 Feb; 293(7):2370-2380. PubMed ID: 29255093
[TBL] [Abstract][Full Text] [Related]
9. Resveratrol Reduces Kidney Injury in a Rat Model of Uremia and is Associated with Increased Expression of Heat Shock Protein 70 (Hsp70).
Sun Z; Zheng W; Teng J; Fang Z; Lin C
Med Sci Monit; 2020 Feb; 26():e919086. PubMed ID: 32040471
[TBL] [Abstract][Full Text] [Related]
10. Crystal structure of the nucleotide-binding domain of mortalin, the mitochondrial Hsp70 chaperone.
Amick J; Schlanger SE; Wachnowsky C; Moseng MA; Emerson CC; Dare M; Luo WI; Ithychanda SS; Nix JC; Cowan JA; Page RC; Misra S
Protein Sci; 2014 Jun; 23(6):833-42. PubMed ID: 24687350
[TBL] [Abstract][Full Text] [Related]
11. Selective toxicity of MKT-077 to cancer cells is mediated by its binding to the hsp70 family protein mot-2 and reactivation of p53 function.
Wadhwa R; Sugihara T; Yoshida A; Nomura H; Reddel RR; Simpson R; Maruta H; Kaul SC
Cancer Res; 2000 Dec; 60(24):6818-21. PubMed ID: 11156371
[TBL] [Abstract][Full Text] [Related]
12. Rhodacyanine dye MKT-077 inhibits in vitro telomerase assay but has no detectable effects on telomerase activity in vivo.
Wadhwa R; Colgin L; Yaguchi T; Taira K; Reddel RR; Kaul SC
Cancer Res; 2002 Aug; 62(15):4434-8. PubMed ID: 12154051
[TBL] [Abstract][Full Text] [Related]
13. Allosteric drugs: the interaction of antitumor compound MKT-077 with human Hsp70 chaperones.
Rousaki A; Miyata Y; Jinwal UK; Dickey CA; Gestwicki JE; Zuiderweg ER
J Mol Biol; 2011 Aug; 411(3):614-32. PubMed ID: 21708173
[TBL] [Abstract][Full Text] [Related]
14. Mortalin inhibitors sensitize K562 leukemia cells to complement-dependent cytotoxicity.
Pilzer D; Saar M; Koya K; Fishelson Z
Int J Cancer; 2010 Mar; 126(6):1428-35. PubMed ID: 19739077
[TBL] [Abstract][Full Text] [Related]
15. The chaperone Hsp70 is a BH3 receptor activated by the pro-apoptotic Bim to stabilize anti-apoptotic clients.
Guo Z; Song T; Wang Z; Lin D; Cao K; Liu P; Feng Y; Zhang X; Wang P; Yin F; Dai J; Zhou S; Zhang Z
J Biol Chem; 2020 Sep; 295(37):12900-12909. PubMed ID: 32651234
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and initial evaluation of YM-08, a blood-brain barrier permeable derivative of the heat shock protein 70 (Hsp70) inhibitor MKT-077, which reduces tau levels.
Miyata Y; Li X; Lee HF; Jinwal UK; Srinivasan SR; Seguin SP; Young ZT; Brodsky JL; Dickey CA; Sun D; Gestwicki JE
ACS Chem Neurosci; 2013 Jun; 4(6):930-9. PubMed ID: 23472668
[TBL] [Abstract][Full Text] [Related]
17. Targeting Allosteric Control Mechanisms in Heat Shock Protein 70 (Hsp70).
Li X; Shao H; Taylor IR; Gestwicki JE
Curr Top Med Chem; 2016; 16(25):2729-40. PubMed ID: 27072701
[TBL] [Abstract][Full Text] [Related]
18. Mortalin sensitizes human cancer cells to MKT-077-induced senescence.
Deocaris CC; Widodo N; Shrestha BG; Kaur K; Ohtaka M; Yamasaki K; Kaul SC; Wadhwa R
Cancer Lett; 2007 Jul; 252(2):259-69. PubMed ID: 17306926
[TBL] [Abstract][Full Text] [Related]
19. Treatment of ras-induced cancers by the F-actin-bundling drug MKT-077.
Tikoo A; Shakri R; Connolly L; Hirokawa Y; Shishido T; Bowers B; Ye LH; Kohama K; Simpson RJ; Maruta H
Cancer J; 2000; 6(3):162-8. PubMed ID: 10882332
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the activity of three different HSP70 inhibitors on apoptosis, cell cycle arrest, autophagy inhibition, and HSP90 inhibition.
Budina-Kolomets A; Balaburski GM; Bondar A; Beeharry N; Yen T; Murphy ME
Cancer Biol Ther; 2014 Feb; 15(2):194-9. PubMed ID: 24100579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
